Latest article: |
|
|
Recent articles: |
|
Leica Microsystems to Develop an Automated HER2 FISH Test with the Leica BOND Staining Platform
 22 Jun 2010: Leica Microsystems GmbH and Abbott have reached an agreement for Abbott to supply fluorescence in situ hybridization (FISH) probes that target the HER2 gene locus. The probes will be used to develop a fully automated FISH solution for HER2 testing on the Leica Microsystems’ BOND™ an automated advanced staining platform.
Leica Microsystems GmbH
|
Agilent Technologies Launches Bio-Inert LC to Characterize Large Biomolecules, New Biological Entities
18 Jun 2010: Agilent Technologies Inc. today introduced the 1260 Infinity bio-inert quaternary liquid chromatography (LC) system designed to characterize and confirm large biomolecules, especially new biological entities (NBEs) and therapeutic monoclonal antibodies. The system is based on the new Agilent 1260 Infinity LC system with quaternary pump module.
Agilent Technologies
|
AnaSpec Introduces New SensoLyte uPA & tPA Assay Kits
 17 Jun 2010: AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. These kits, optimized for inhibitor screening, contain high-performance fluorogenic substrates which exhibit high reactivity and low background signal.
AnaSpec Inc.
|
Achieve Fast Solvent Removal with the Porvair Ultravap Blowdown Station
 17 Jun 2010: Designed to quickly and safely remove solvents from 96 or 384-well plates, the Ultravap™ Blowdown Station from Porvair Sciences Ltd. is a versatile tool proven to optimise microplate sample preparation productivity. The Ultravap™ achieves high sample throughput through advanced evaporator head technology and an innovative manifold design, which directly injects heated nitrogen into each individual well of the microplate simultaneously.
Porvair Sciences Ltd
|
Promega and Cellular Dynamics Partner to Validate Stem Cell-Based In Vitro Assays for Predicting Drug-Induced Cardiotoxicity
 15 Jun 2010: Cellular Dynamics International (CDI) and Promega have entered into a research collaboration with the goal of bringing more relevant and highly predictive toxicity testing to the drug discovery process. Pharmaceutical discovery scientists will now be able to combine bioassays with human cardiomyocytes to improve prediction of unintentional, detrimental side effects that have previously remained undetected until late in the development process or after release of the drug to the general public.
Cellular Dynamics International
|
Esco Announces New Generation of Best-Selling Labculture Class II Biological Safety Cabinets
 14 Jun 2010: Esco announces the release of new generation Labculture Class II Biological Safety Cabinets, the industry's most certified biosafety cabinet product line. New generation Labculture Class II Biological Safety Cabinets feature improved design, an enhanced user interface, simplified menu navigation and a new quickstart mode.
Esco Micro Pte Ltd
|
Lonza Introduces Clonetics® Human Retinal Pigment Epithelial Cells & RtEGM™ Growth Medium
14 Jun 2010: Lonza is pleased to announce the availability of cryopreserved Clonetics® Human Retinal Pigment Epithelial (hRPE) Cells and optimized RtEGM™ Growth Medium BulletKit® for ophthalmologic research including age-related macular degeneration, retinistis pigmentosa, and gene expression profiles of RPE.
Lonza Group Ltd
|
UVP Announces Major Software Upgrade for VisionWorksLS Analysis Software
 14 Jun 2010: UVP, LLC announces a major upgrade to the VisionWorks®LS Software, configured with UVP’s BioImaging Systems, making this version the most streamlined, efficient design for personalized workflow. The new VisionWorksLS 7.0 software includes a redesigned interface, portable analysis data, capture templates and compatibility with Windows 7.
UVP, LLC.
|
AACC Announces Largest Ever Clinical Lab Expo
09 Jun 2010: The American Association for Clinical Chemistry (AACC) announces that the 2010 Clinical Lab Expo being held July 27 – 29 as part of its 2010 Annual Meeting at the Anaheim Convention Center in Anaheim, CA is the largest ever with over 1,900 booths and more than 650 companies exhibiting. The Clinical Lab Expo maintains its position as the premier event of its kind in the world.
AACC
|
16 Aug 2010: ACD/Labs will highlight a recent addition to its line of ADMET prediction software aimed at helping researchers detect enzyme inhibition in the early stages of the discovery process. ACD/Labs CYP450 Regioselectivity module is capable of predicting sites of metabolic activity for almost any compound. Students and professors can also receive a free copy of ACD/NMR Processor Academic Edition.
